Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Cogent Biosciences Inc (NASDAQ: COGT) closed the day trading at $34.74 down -2.20% from the previous closing price of $35.52. In other words, the price has decreased by -$2.20 from its previous closing price. On the day, 2.51 million shares were traded. COGT stock price reached its highest trading level at $35.89 during the session, while it also had its lowest trading level at $34.08.
Ratios:
For a better understanding of COGT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.38 and its Current Ratio is at 6.38. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On November 10, 2025, Stifel Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $40.
On October 16, 2025, Stifel started tracking the stock assigning a Hold rating and target price of $16.Stifel initiated its Hold rating on October 16, 2025, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 26 ’25 when Kearns Evan sold 65,000 shares for $38.70 per share. The transaction valued at 2,515,500 led to the insider holds 109,398 shares of the business.
Green John L. sold 77,000 shares of COGT for $2,978,360 on Dec 26 ’25. The Chief Financial Officer now owns 131,834 shares after completing the transaction at $38.68 per share. On Dec 26 ’25, another insider, Sachs Jessica, who serves as the Chief Medical Officer of the company, sold 82,642 shares for $38.70 each. As a result, the insider received 3,198,245 and left with 133,938 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 5332783616 and an Enterprise Value of 4726325248.
Stock Price History:
The Beta on a monthly basis for COGT is 0.50, which has changed by 3.3101735 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $43.73, while it has fallen to a 52-week low of $3.72. The 50-Day Moving Average of the stock is 8.78%, while the 200-Day Moving Average is calculated to be 131.79%.
Shares Statistics:
Over the past 3-months, COGT traded about 3.22M shares per day on average, while over the past 10 days, COGT traded about 2338000 shares per day. A total of 139.83M shares are outstanding, with a floating share count of 123.92M. Insiders hold about 18.71% of the company’s shares, while institutions hold 87.77% stake in the company. Shares short for COGT as of 1765756800 were 14717421 with a Short Ratio of 4.57, compared to 1763078400 on 15477473. Therefore, it implies a Short% of Shares Outstanding of 14717421 and a Short% of Float of 10.75.
Earnings Estimates
As of right now, 11.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.38 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.96 and -$2.47 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$1.73, with 11.0 analysts recommending between -$0.88 and -$2.25.
